Aktiesnakken — Juni 2012
-
Today some surprisingly good clinical study results were presented at ASCO here in Chicago. It involved the monoclonal antibody, daratumumab.
Has anyone ever even heard of daratumumab? A lot has been written about elotuzumab this past year. But daratumumab has sort of been flying under the radar. -
hvor har du fundet det w?
-
-
tak
-
-
Nigel Farage's taler er altid underholdende! hans nyeste hvor han sviner hans kollegaer og forklarer dem lidt om problemerne i EU:
-
-
renten på den spanske 10årige ryger i vejret pt - lige nu på 6.773
-
-
Update: Vi beklager nedetiden efter at vores database server gik i udu. Dette er nu fikset, og i kan alle bruge PI igen!
Happy PI'ing!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind